Opioid Use Disorder Medication Initiation Constraint Verification Benchmark
- Records
- 5000
- Size
- 0.5GB
- Format
- JSON
- Provider
MOBIUSI INC- Updated
- v1.02026-11-04
This benchmark uses structured JSON to represent patient cases involving opioid use disorder, applicable clinical constraints, and candidate medication initiation plans. Labels indicate whether a plan violates a constraint, the severity and codes of any violations, and the rationale for the assessment. It supports domain evaluation of models that identify relevant patient and plan details, check applicable conditions, and explain constraint judgments in addiction medicine. Dataset size and case provenance are not specified in the provided information; consult the dataset documentation for details.
Overview
Dataset Insights
Preview
Sample Examples
Schema
Technical Specifications
| Field | Type | Description |
|---|---|---|
| file_name | string | File name |
| case_input | object | Original structured JSON input describing the patient, applicable clinical constraints, and candidate medication initiation plan. |
| violation_severity | string | Overall severity of the identified violation, or none when no violation is present. |
| assessment_rationale | string | Concise explanation of the constraint assessment, including relevant patient facts and plan details. |
| constraint_violation | boolean | Whether the candidate medication initiation plan violates at least one applicable clinical constraint or safety condition. |
| violated_constraint_codes | array | Codes of the supplied clinical constraints violated by the candidate plan. |
Trust
Compliance Statement
Authorization Type
Proprietary - Commercial AI Training License (No Redistribution)
Commercial Use
Requires exclusive subscription or authorization contract (monthly or per-invocation charging)
Privacy and Anonymization
No PII, no real company names, simulated scenarios follow industry standards
Compliance System
Compliant with China's Data Security Law / EU GDPR / supports enterprise data access logs
FAQ
Frequently Asked Questions
- What data does the benchmark contain?
- Each sample uses structured JSON to describe a patient case, applicable clinical constraints, and a candidate medication initiation plan. It includes a violation label, severity, violated constraint codes, and assessment rationale. Consult the dataset documentation for its size and case provenance.
- Which capabilities can it evaluate?
- It can evaluate whether a model identifies relevant facts in patient cases and plans, checks applicable constraints, determines whether a violation is present, and explains its assessment. It may also support domain evaluation and safety research for medical AI.
- Can this benchmark be used to make clinical decisions?
- No. It is a model evaluation benchmark, not diagnostic or treatment advice, and it does not replace clinical professionals, current guidelines, or institutional procedures. Any clinical application requires independent validation and qualified professional oversight.
- How can I access the data and verify its license?
- Check the dataset listing or provider's license terms for access options, permitted uses, and commercial-use conditions. Before use, review privacy, redistribution, and research ethics requirements. The supplied information does not specify an access method or license.
Can't find the data you need?
Post a request and let data providers reach out to you.
Get this Dataset
High-quality data, ready for your next AI breakthrough.
Cite this Work
@dataset{Mobiusi2026,
title={Opioid Use Disorder Medication Initiation Constraint Verification Benchmark},
author={MOBIUSI INC},
year={2026},
url={https://www.mobiusi.com/datasets/f53f5ffc711c2fedb3e73d06b18742c4?dataset_task_cate_id=1},
urldate={2026-10-12},
keywords={opioid use disorder dataset,medication initiation constraints,addiction medicine benchmark,clinical constraint reasoning,medication safety evaluation,medical AI evaluation,clinical JSON data,clinical rule verification},
version={1.0}
}Using this in research? Please cite us.